News

The Fentanyl transdermal system utilizes a proprietary matrix design which incorporates the drug into the adhesive. It is indicated for the management of persistent moderate to severe chronic

As president, Mr Cunard will be responsible for all company activities including daily operations, strategy and business development activities related to the organization’s commercial initiatives. Before coming to

The UK Government’s technology strategy board has helped facilitate this innovative arrangement between Pfizer and UCB and will continue to support Cyclofluidic by co-funding its R&D. The aim

Under a previously announced collaboration agreement between Raptor and University of California, San Diego (UCSD) to evaluate the safety and potential efficacy of cysteamine in non-alcoholic steatohepatitis (NASH)

According to the company, the new model is designed to be more effective at driving sales growth by better meeting the diverse needs of multiple customers as well

The molecular diagnostics business will operate under the name Myriad Genetics, Inc and the research and drug development businesses will operate under the name Myriad Pharmaceuticals, Inc. The

This move is said to be part of Nanosyn’s strategy to become a worldwide leader in drug discovery services and reflects the company’s evolution from a small regional

This new research agreement is the second collaboration agreement signed between Genentech and Nerviano Medical Sciences (NMS) in less than 12 months. Terms of the multi-year collaboration include

Dr Sorensen is currently board director, president and CEO of Ascenta Therapeutics. Dr Sorensen is an experienced leader and administrator in cancer therapeutics and cancer drug development. John